Table 4 Asthma medications and patient’s control in the last 3 months
Medications | G 1: Covid-19 infected with asthma (312) | G 3: Covid-19 non-infected with asthma (300) | Remarks |
|---|---|---|---|
ICS | 9 (2.9%) | 24 (8%) | |
ICS + LABA | 303 (97%) | 276 (92%) | |
Inhaled LAMA | 43 (13.8%) | 32 (10.7%) | |
Leukotriene’s modifier | 249 (79.8%) | 218 (72.7%) | |
OCS | 23 (7.4%) | 5 (1.7%) | |
Biological treatment | 4 (1%) | 1 (0.33%) | |
Fully controlled | 183 (58.6%) | 180 (60%) | |
Partially controlled | 118 (37.8%) | 113 (37.7%) | |
Non-controlled | 11 (3.5%) | 7 (2.3%) |